Health Care Finance – Page 58 – medicarereport.org

Wednesday, December 17, 2025

Latest:

CMS Health Care Finance Health Care Redesign Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook September 27, 2023September 27, 2023 CMS, Healthcare Costs, medicare, Medicare Advantage, Medicare Drug Price Negotiation Program, Medicare Part D

How Medicare’s New Drug Price Negotiation Program Could Expand Access to Selected Drugs

(By Juliette Cubanski, Anthony Damico, and Tricia Neuman for The Kaiser Family Foundation Published: Sep 26, 2023) Medicare recently announced

CMS Health Care Finance Medicare Advantage Part D/Prescription Drugs

Eileen Cook September 27, 2023September 27, 2023 Healthcare Costs, Increase in Medicare Advantage premiums, Medicare Advantage, Medicare Part D

Medicare Advantage premiums to remain stable in 2024

(By Jakob Emerson for Becker’s Hospital Review) Medicare Advantage and Medicare Part D premiums, benefits and plan choices won’t be

CMS Health Care Finance Medicare - General Medicare Advantage Medigap Part D/Prescription Drugs

Eileen Cook September 20, 2023September 20, 2023 CMS, Healthcare Costs, medicare, Medicare Advantage, Medicare Part D

5 ways Medicare Advantage and traditional Medicare differ on affordability: Survey

(By Rylee Wilson for Becker’s Hospital Review) Around 1 in 5 adults with Medicare reported high healthcare costs in the

Health Care Finance Part D/Prescription Drugs

Eileen Cook September 19, 2023September 19, 2023 Biosimilars drugs, Healthcare Costs, Medicare Part D, PBM

Save Billions or Stick With Humira? Drug Brokers Steer Americans to the Costly Choice

(By Arthur Allen for KFF Health News) Tennessee last year spent $48 million on a single drug, Humira — about

Health Care Finance Medicare - General Part D/Prescription Drugs

Eileen Cook September 18, 2023September 18, 2023 CMS, Healthcare Costs, medicare, Prescription drug costs

What are the recent and forecasted trends in prescription drug spending?

(By Emma Wager, Imani Telesford, Cynthia Cox, and Krutika Amin for Kaiser Family Foundation published September 15, 2023) Prescription drug

Health Care Finance Health Insurance Legal Actions/Court Decisions

Eileen Cook September 15, 2023September 15, 2023 Cigna, Claims Denials and Appeals, Health care claims, Lawsuit

Cigna sued by shareholder following ProPublica report on claims denials

(By Jakob Emerson for Becker’s Hospital Review) A shareholder is suing the Cigna Group in Delaware’s Court of Chancery to

CMS Health Care Finance Medicare Advantage

Eileen Cook September 14, 2023September 14, 2023 Aetna, CVS Health, Healthcare Finance, Medicare Advantage, Medicare Advantage Star Ratings

CVS Health ‘optimistic’ its Medicare Advantage star ratings will improve

(By Rylee Wilson for Becker’s Hospital Review) CVS Health CEO Karen Lynch said she is “optimistic” Aetna will improve its

Health Care Finance Medicare - General Medicare Advantage Medigap Part D/Prescription Drugs

Eileen Cook September 13, 2023September 13, 2023 medicare, Medicare Advantage, Medicare Part D, Older Adults, Zero-premium Medicare Advantage plans

Is your zero-premium Medicare Advantage plan really free

Medicare open enrollment – also known as the annual election period (AEP) – refers to an enrollment window that takes

Health Care Finance HHS Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook September 12, 2023September 12, 2023 CMS, HHS, medicare, Medicare Advantage, Medicare Part D, Older Adults

What 8 recent studies found about Medicare Advantage

(By Rylee Wilson for Becker’s Hospital Review) Much of Medicare Advantage growth is driven by people switching to the program from